MAR 29, 2018 7:42 AM PDT

An Off Switch for Inflammation?

WRITTEN BY: Kara Marker

Regulating inflammation is vital for controlling various autoimmune and inflammatory diseases. Inflammation is important as a response to pathogenic invasions, but when inflammation goes overboard or occurs without reason, it can cause severe damage. Scientists from Trinity College Dublin now introduce a way to turn inflammation “off.”

Credit: A macrophage of a mouse forming two processes to phagocytize two smaller particles, possibly pathogens.

A metabolite of glucose, called itaconate, is able to “switch off” macrophage activity, scientists found. This finding comes from a research group that has been studying macrophages for six years; it is believed to be the most important finding to date, with the potential to treat inflammatory diseases like arthritis, inflammatory bowel disease, and heart disease.

Macrophages are immune cells that identify, engulf, and destroy foreign particles through a process called phagocytosis. Macrophages also act as antigen-presenting cells, which means they take pieces of foreign particles and bring them to the attention of T cells, another important player in the immune system, which can initiate inflammation if the antigen is deemed to be indicative of a looming infection.

"It is well known that macrophages cause inflammation, but we have just found that they can be coaxed to make a biochemical called itaconate,” explained study leader Luke O’Neill. “This functions as an important brake, or off-switch, on the macrophage, cooling the heat of inflammation in a process never before described."

According to a 2016 Cell Metabolism study, itaconate is one of the most highly induced metabolites in activated macrophages, and it is involved in the regulation of important cellular functions as well as cytokine production. Cytokines are chemical messengers of the immune system that can, for example, tell immune cells to turn inflammation on or off.

How does it work? Macrophages transform glucose into itaconate, which blocks the production of inflammatory factors and prevents lethal inflammation that occurs during infection. Itaconate can directly alter several proteins involved in the inflammatory process in a novel chemical reaction.

Going forward, researchers ask: how is the relationship between macrophages, itaconate, and inflammation related to the onset and development of disease? How can this relationship be applied to the development of new anti-inflammatory drugs?

The present study was published in the journal Nature.

Sources: British Society for Immunology, Trinity College Dublin

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
SEP 16, 2020
Immunology
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
SEP 16, 2020
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
Scientists have discovered that depressed individuals show higher levels of inflammation as well as elevated fat concent ...
OCT 01, 2020
Immunology
Immune Cells and MS: The Good, the Bad, and the Maybe
OCT 01, 2020
Immune Cells and MS: The Good, the Bad, and the Maybe
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
Loading Comments...